Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125230692 | 12523069 | 2 | F | 20160819 | 20160701 | 20160824 | EXP | US-ALLERGAN-1661698US | ALLERGAN | 86.00 | YR | F | Y | 0.00000 | 20160824 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125230692 | 12523069 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 100 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD | ||||||||
| 125230692 | 12523069 | 2 | SS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 100 UNITS, SINGLE | 103000 | POWDER FOR INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125230692 | 12523069 | 1 | Muscle tightness |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125230692 | 12523069 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125230692 | 12523069 | Confusional state | |
| 125230692 | 12523069 | Fall | |
| 125230692 | 12523069 | Off label use | |
| 125230692 | 12523069 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125230692 | 12523069 | 1 | 20160531 | 20160531 | 0 | |
| 125230692 | 12523069 | 2 | 20160531 | 20160531 | 0 |